At the MRC Clinical Trials Unit at UCL, we carry out clinical trials, observational studies, meta-analyses, and methodology research. We focus on research questions that are internationally important, and relevant for patients, policymakers, and health workers.

Latest News

Hormone therapy can delay prostate cancer spread in people treated with surgery and radiotherapy

People with prostate cancer who have had surgery to remove their prostate, and then received radiotherapy, can benefit from hormone therapy.

20 Sep

Adding abiraterone to standard therapy helps people with metastatic prostate cancer to live longer

Adding the drug abiraterone to standard hormone therapy helps people with prostate cancer that has spread to other parts of the body to live longer.

20 Sep

The REFINE Trial is presented at the European Society for Medical Oncology Congress

Sophie Merrick presented the REFINE trial at the ESMO Congress in Paris on the 12th September

20 Sep

Dolutegravir-based HIV treatment is better for babies and young children

Babies and young children treated with the anti-HIV drug dolutegravir, in combination with other anti-HIV drugs, are more likely to keep the virus under control, compared to those treated with standard anti-HIV treatment…

31 Aug

See our Latest News

Research Themes


Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types


Major international clinical trials answering questions of global public health significance

Neurodegenerative diseases

New generation of innovative multi-arm, multi stage platform clinical trials to identify and test new therapeutic treatments in neurodegenerative diseases


Development of methods with direct impact on the design, conduct and analysis of studies

Other Research & Policy

This section will capture projects outside the current QQR themes